Company · Saint-Laurent, Quebec, Canada
Sivem Pharmaceuticals Ulc
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 342
- 282 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 446
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| ALENDRONATE | 02299712 | Marketed | |
| ALFUZOSIN | 02447576 | Marketed | |
| AMIODARONE | 02385465 | Marketed | |
| AMLODIPINE | 02385783 | Marketed | |
| AMLODIPINE | 02385791 | Marketed | |
| AMLODIPINE | 02385805 | Marketed | |
| AMOXICILLIN | 02401509 | Marketed | |
| AMOXICILLIN | 02401541 | Marketed | |
| ANASTROZOLE | 02529904 | Marketed | |
| APIXABAN | 02530708 | Marketed | |
| APIXABAN | 02530716 | Marketed | |
| ARIPIPRAZOLE | 02534320 | Marketed | |
| ARIPIPRAZOLE | 02534339 | Marketed | |
| ARIPIPRAZOLE | 02534347 | Marketed | |
| ARIPIPRAZOLE | 02534355 | Marketed | |
| ARIPIPRAZOLE | 02534363 | Marketed | |
| ARIPIPRAZOLE | 02534371 | Marketed | |
| ATENOLOL | 02238316 | Marketed | |
| ATENOLOL | 02238318 | Marketed | |
| ATENOLOL | 02541564 | Marketed | |
| ATOMOXETINE | 02445883 | Marketed | |
| ATOMOXETINE | 02445905 | Marketed | |
| ATOMOXETINE | 02445913 | Marketed | |
| ATOMOXETINE | 02445948 | Marketed | |
| ATOMOXETINE | 02445956 | Marketed | |
| ATORVASTATIN-10 | 02411350 | Marketed | |
| ATORVASTATIN-20 | 02411369 | Marketed | |
| ATORVASTATIN-40 | 02411377 | Marketed | |
| ATORVASTATIN-80 | 02411385 | Marketed | |
| AZITHROMYCIN | 02442434 | Marketed | |
| BACLOFEN | 02544660 | Marketed | |
| BACLOFEN | 02544679 | Marketed | |
| BISOPROLOL TABLETS | 02495562 | Marketed | |
| BISOPROLOL TABLETS | 02495570 | Marketed | |
| CANDESARTAN | 02388707 | Marketed | |
| CANDESARTAN | 02388715 | Marketed | |
| CANDESARTAN | 02528258 | Marketed | |
| CANDESARTAN | 02528266 | Marketed | |
| CANDESARTAN HCT | 02394812 | Marketed | |
| CARVEDILOL | 02248752 | Marketed | |
| CARVEDILOL | 02248753 | Marketed | |
| CARVEDILOL | 02248754 | Marketed | |
| CARVEDILOL | 02248755 | Marketed | |
| CELECOXIB | 02429675 | Marketed | |
| CELECOXIB | 02429683 | Marketed | |
| CEPHALEXIN | 02495651 | Marketed | |
| CETIRIZINE | 02534126 | Marketed | |
| CIPROFLOXACIN | 02386119 | Marketed | |
| CIPROFLOXACIN | 02386127 | Marketed | |
| CITALOPRAM | 02387948 | Marketed | |
| CITALOPRAM | 02387956 | Marketed | |
| CITALOPRAM | 02387964 | Marketed | |
| CLARITHROMYCIN | 02442469 | Marketed | |
| CLARITHROMYCIN | 02442485 | Marketed | |
| CLONIDINE | 02538490 | Marketed | |
| CLONIDINE | 02538504 | Marketed | |
| CLONIDINE | 02540061 | Marketed | |
| CLOPIDOGREL | 02385813 | Marketed | |
| CYCLOBENZAPRINE | 02424584 | Marketed | |
| DESVENLAFAXINE | 02554968 | Marketed | |
| DESVENLAFAXINE | 02554976 | Marketed | |
| DILTIAZEM CD | 02445999 | Marketed | |
| DILTIAZEM CD | 02446006 | Marketed | |
| DILTIAZEM CD | 02446014 | Marketed | |
| DILTIAZEM CD | 02446022 | Marketed | |
| DOMPERIDONE | 02238341 | Marketed | |
| DONEPEZIL | 02420597 | Marketed | |
| DONEPEZIL | 02420600 | Marketed | |
| DULOXETINE | 02453630 | Marketed | |
| DULOXETINE | 02453649 | Marketed | |
| DUTASTERIDE | 02429012 | Marketed | |
| ENALAPRIL | 02442957 | Marketed | |
| ENALAPRIL | 02442965 | Marketed | |
| ENALAPRIL | 02442973 | Marketed | |
| ENALAPRIL | 02442981 | Marketed | |
| ESCITALOPRAM | 02429039 | Marketed | |
| ESCITALOPRAM | 02429047 | Marketed | |
| ESOMEPRAZOLE | 02442493 | Marketed | |
| ESOMEPRAZOLE | 02442507 | Marketed | |
| FAMOTIDINE | 02549107 | Marketed | |
| FAMOTIDINE | 02549115 | Marketed | |
| FINASTERIDE | 02447541 | Marketed | |
| FINASTERIDE | 02447568 | Marketed | |
| FLUCONAZOLE | 02534886 | Marketed | |
| FLUCONAZOLE | 02534894 | Marketed | |
| FLUOXETINE | 02374447 | Marketed | |
| FLUOXETINE | 02374455 | Marketed | |
| GABAPENTIN | 02246314 | Marketed | |
| GABAPENTIN | 02246315 | Marketed | |
| GABAPENTIN | 02246316 | Marketed | |
| GABAPENTIN | 02388200 | Marketed | |
| GABAPENTIN | 02388219 | Marketed | |
| GALANTAMINE ER | 02562154 | Marketed | |
| GALANTAMINE ER | 02562162 | Marketed | |
| GALANTAMINE ER | 02562170 | Marketed | |
| IMATINIB | 02521202 | Marketed | |
| IMATINIB | 02521210 | Marketed | |
| IRBESARTAN | 02385287 | Marketed | |
| IRBESARTAN | 02385295 | Marketed | |
| IRBESARTAN | 02385309 | Marketed | |
| IRBESARTAN HCT | 02385317 | Marketed | |
| IRBESARTAN HCT | 02385325 | Marketed | |
| IRBESARTAN HCT | 02385333 | Marketed | |
| LAMOTRIGINE | 02428202 | Marketed | |
| LAMOTRIGINE | 02428210 | Marketed | |
| LAMOTRIGINE | 02428229 | Marketed | |
| LANSOPRAZOLE | 02385767 | Marketed | |
| LANSOPRAZOLE | 02410389 | Marketed | |
| LEFLUNOMIDE | 02543575 | Marketed | |
| LEFLUNOMIDE | 02543583 | Marketed | |
| LETROZOLE | 02524244 | Marketed | |
| LEVETIRACETAM | 02442531 | Marketed | |
| LEVETIRACETAM | 02442558 | Marketed | |
| LEVETIRACETAM | 02442566 | Marketed | |
| LISINOPRIL TABLETS | 02554488 | Marketed | |
| LISINOPRIL TABLETS | 02554496 | Marketed | |
| LISINOPRIL TABLETS | 02554518 | Marketed | |
| LOSARTAN | 02388790 | Marketed | |
| LOSARTAN | 02388804 | Marketed | |
| LOSARTAN | 02388812 | Marketed | |
| LOSARTAN HCT | 02388960 | Marketed | |
| LOSARTAN HCT | 02388979 | Marketed | |
| LOSARTAN HCT DS | 02388987 | Marketed | |
| MEMANTINE | 02446049 | Marketed | |
| METFORMIN | 02385341 | Marketed | |
| METFORMIN | 02385368 | Marketed | |
| METOPROLOL-L | 02442116 | Marketed | |
| METOPROLOL-L | 02442124 | Marketed | |
| METOPROLOL-L | 02442132 | Marketed | |
| MIRTAZAPINE | 02496666 | Marketed | |
| MIRTAZAPINE | 02496674 | Marketed | |
| MIRTAZAPINE | 02496682 | Marketed | |
| MOMETASONE | 02551756 | Marketed | |
| MONTELUKAST | 02382458 | Marketed | |
| MONTELUKAST | 02382466 | Marketed | |
| MONTELUKAST | 02382474 | Marketed | |
| OLANZAPINE | 02385864 | Marketed | |
| OLANZAPINE | 02385872 | Marketed | |
| OLANZAPINE | 02385880 | Marketed | |
| OLANZAPINE | 02385899 | Marketed | |
| OLANZAPINE | 02385902 | Marketed | |
| OLANZAPINE | 02385910 | Marketed | |
| OLANZAPINE ODT | 02343665 | Marketed | |
| OLANZAPINE ODT | 02343673 | Marketed | |
| OLANZAPINE ODT | 02343681 | Marketed | |
| OLANZAPINE ODT | 02343703 | Marketed | |
| OMEPRAZOLE-20 | 02411857 | Marketed | |
| ONDANSETRON | 02541424 | Marketed | |
| ONDANSETRON | 02541432 | Marketed | |
| PANTOPRAZOLE | 02428172 | Marketed | |
| PANTOPRAZOLE | 02428180 | Marketed | |
| PANTOPRAZOLE MAGNESIUM | 02519534 | Marketed | |
| PAROXETINE | 02388227 | Marketed | |
| PAROXETINE | 02388235 | Marketed | |
| PAROXETINE | 02388243 | Marketed | |
| PERINDOPRIL ERBUMINE | 02479877 | Marketed | |
| PERINDOPRIL ERBUMINE | 02479885 | Marketed | |
| PERINDOPRIL ERBUMINE | 02479893 | Marketed | |
| PERINDOPRIL ERBUMINE/ INDAPAMIDE | 02479834 | Marketed | |
| PERINDOPRIL ERBUMINE/ INDAPAMIDE HD | 02479842 | Marketed | |
| PRAMIPEXOLE | 02309122 | Marketed | |
| PRAMIPEXOLE | 02309130 | Marketed | |
| PRAMIPEXOLE | 02309149 | Marketed | |
| PRAMIPEXOLE | 02309157 | Marketed | |
| PRAVASTATIN | 02389703 | Marketed | |
| PRAVASTATIN | 02389738 | Marketed | |
| PRAVASTATIN | 02389746 | Marketed | |
| PREGABALIN | 02403692 | Marketed | |
| PREGABALIN | 02403706 | Marketed | |
| PREGABALIN | 02403714 | Marketed | |
| PREGABALIN | 02403722 | Marketed | |
| PREGABALIN | 02403730 | Marketed | |
| QUETIAPINE | 02317893 | Marketed | |
| QUETIAPINE | 02317907 | Marketed | |
| QUETIAPINE | 02317923 | Marketed | |
| QUETIAPINE | 02317931 | Marketed | |
| QUETIAPINE XR | 02417359 | Marketed | |
| QUETIAPINE XR | 02417367 | Marketed | |
| QUETIAPINE XR | 02417375 | Marketed | |
| QUETIAPINE XR | 02417383 | Marketed | |
| QUETIAPINE XR | 02417391 | Marketed | |
| RABEPRAZOLE | 02385449 | Marketed | |
| RABEPRAZOLE | 02385457 | Marketed | |
| RAMIPRIL | 02287927 | Marketed | |
| RAMIPRIL | 02287935 | Marketed | |
| RAMIPRIL | 02287943 | Marketed | |
| RAMIPRIL | 02308363 | Marketed | |
| RISEDRONATE | 02411407 | Marketed | |
| RISPERIDONE | 02533804 | Marketed | |
| RISPERIDONE | 02533928 | Marketed | |
| RISPERIDONE | 02533936 | Marketed | |
| RISPERIDONE | 02533944 | Marketed | |
| RISPERIDONE | 02533952 | Marketed | |
| RISPERIDONE | 02533960 | Marketed | |
| RIVAROXABAN | 02541467 | Marketed | |
| RIVAROXABAN | 02541475 | Marketed | |
| RIVAROXABAN | 02541483 | Marketed | |
| RIVAROXABAN | 02541491 | Marketed | |
| RIZATRIPTAN ODT | 02446111 | Marketed | |
| RIZATRIPTAN ODT | 02446138 | Marketed | |
| ROSUVASTATIN | 02411628 | Marketed | |
| ROSUVASTATIN | 02411636 | Marketed | |
| ROSUVASTATIN | 02411644 | Marketed | |
| ROSUVASTATIN | 02411652 | Marketed | |
| SERTRALINE | 02386070 | Marketed | |
| SERTRALINE | 02386089 | Marketed | |
| SERTRALINE | 02386097 | Marketed | |
| SILDENAFIL | 02400693 | Marketed | |
| SILDENAFIL | 02400707 | Marketed | |
| SILDENAFIL | 02400715 | Marketed | |
| SIMVASTATIN | 02386291 | Marketed | |
| SIMVASTATIN | 02386305 | Marketed | |
| SIMVASTATIN | 02386313 | Marketed | |
| SIMVASTATIN | 02386321 | Marketed | |
| SIMVASTATIN | 02386348 | Marketed | |
| SITAGLIPTIN | 02529033 | Marketed | |
| SITAGLIPTIN | 02529041 | Marketed | |
| SITAGLIPTIN | 02529068 | Marketed | |
| SITAGLIPTIN-METFORMIN | 02529157 | Marketed | |
| SITAGLIPTIN-METFORMIN | 02529165 | Marketed | |
| SITAGLIPTIN-METFORMIN | 02529173 | Marketed | |
| SUMATRIPTAN | 02546035 | Marketed | |
| SUMATRIPTAN | 02546043 | Marketed | |
| SUMATRIPTAN DF | 02385570 | Marketed | |
| SUMATRIPTAN DF | 02385589 | Marketed | |
| TADALAFIL | 02536676 | Marketed | |
| TADALAFIL | 02536684 | Marketed | |
| TADALAFIL | 02536692 | Marketed | |
| TADALAFIL | 02536706 | Marketed | |
| TAMSULOSIN CR | 02429667 | Marketed | |
| TELMISARTAN | 02390345 | Marketed | |
| TELMISARTAN | 02390353 | Marketed | |
| TELMISARTAN HCTZ | 02390302 | Marketed | |
| TELMISARTAN HCTZ | 02390310 | Marketed | |
| TENOFOVIR | 02523922 | Marketed | |
| TERBINAFINE | 02385279 | Marketed | |
| TOPIRAMATE | 02389460 | Marketed | |
| TOPIRAMATE | 02389487 | Marketed | |
| TOPIRAMATE | 02553880 | Marketed | |
| TRANDOLAPRIL | 02526565 | Marketed | |
| TRANDOLAPRIL | 02526573 | Marketed | |
| TRANDOLAPRIL | 02526581 | Marketed | |
| VALACYCLOVIR | 02442000 | Marketed | |
| VALACYCLOVIR | 02553511 | Marketed | |
| VALSARTAN | 02384523 | Marketed | |
| VALSARTAN | 02384531 | Marketed | |
| VALSARTAN | 02384558 | Marketed | |
| VALSARTAN | 02384566 | Marketed | |
| VALSARTAN HCT | 02384736 | Marketed | |
| VALSARTAN HCT | 02384744 | Marketed | |
| VALSARTAN HCT | 02384752 | Marketed | |
| VALSARTAN HCT | 02384760 | Marketed | |
| VENLAFAXINE XR | 02385929 | Marketed | |
| VENLAFAXINE XR | 02385937 | Marketed | |
| VENLAFAXINE XR | 02385945 | Marketed | |
| ZOPICLONE | 02385821 | Marketed | |
| ZOPICLONE | 02385848 | Marketed | |
| ACETAMINOPHEN | 02571277 | Approved | |
| BISOPROLOL TABLETS | 02554240 | Approved | |
| BISOPROLOL TABLETS | 02554259 | Approved | |
| CAPECITABINE | 02528126 | Approved | |
| CAPECITABINE | 02528150 | Approved | |
| CINACALCET | 02567911 | Approved | |
| CINACALCET | 02567938 | Approved | |
| CINACALCET | 02567946 | Approved | |
| CIPROFLOXACIN | 02386135 | Approved | |
| DOMPERIDONE TABLETS | 02567199 | Approved | |
| EZETIMIBE | 02429659 | Dormant | |
| LISINOPRIL | 02386232 | Dormant | |
| LISINOPRIL | 02386240 | Dormant | |
| LISINOPRIL | 02386259 | Dormant | |
| MYCOPHENOLATE MOFETIL | 02569469 | Approved | |
| MYCOPHENOLATE MOFETIL | 02569477 | Approved | |
| ONDANSETRON ODT | 02572001 | Approved | |
| ONDANSETRON ODT | 02572028 | Approved | |
| PREGABALIN | 02403749 | Approved | |
| RISPERIDONE | 02571994 | Approved | |
| SUMATRIPTAN | 02546027 | Approved | |
| SUMATRIPTAN DF | 02385562 | Approved | |
| TOPIRAMATE | 02516780 | Approved | |
| ZOLMITRIPTAN | 02546833 | Approved | |
| ZOLMITRIPTAN ODT | 02546841 | Approved | |
| AMITRIPTYLINE | 02451786 | Cancelled Post Market | |
| AMITRIPTYLINE | 02451794 | Cancelled Post Market | |
| AMITRIPTYLINE | 02451808 | Cancelled Post Market | |
| AMOXICILLIN | 02401495 | Cancelled Post Market | |
| AMOXICILLIN GRANULES FOR ORAL SUSPENSION | 02401533 | Cancelled Pre Market | |
| AMOXICILLIN SUGAR-REDUCED GRANULES FOR ORAL SUSPENSION | 02401568 | Cancelled Pre Market | |
| AMOXICILLIN SUGAR-REDUCED GRANULES FOR ORAL SUSPENSION | 02401576 | Cancelled Post Market | |
| ATENOLOL | 02247182 | Cancelled Post Market | |
| ATORVASTATIN | 02387891 | Cancelled Post Market | |
| ATORVASTATIN | 02387905 | Cancelled Post Market | |
| ATORVASTATIN | 02387913 | Cancelled Post Market | |
| ATORVASTATIN | 02387921 | Cancelled Post Market | |
| BICALUTAMIDE | 02382423 | Cancelled Post Market | |
| BISOPROLOL | 02383055 | Cancelled Post Market | |
| BISOPROLOL | 02383063 | Cancelled Post Market | |
| CANDESARTAN | 02388693 | Cancelled Post Market | |
| CIPROFLOXACIN | 02386100 | Cancelled Pre Market | |
| CLONAZEPAM | 02442027 | Cancelled Post Market |
Showing 300 of 342 drug products. For the rest, search Health Canada’s database.
Notices of Compliance
Newest first.
- MYCOPHENOLATE MOFETILOctober 8, 2026 · NOC 38427 · Supplement to an Abbreviated New Drug Submission (SANDS)
- EZETIMIBESeptember 29, 2026 · NOC 38378 · Abbreviated New Drug Submission (ANDS)
- ONDANSETRON ODTSeptember 28, 2026 · NOC 38373 · Abbreviated New Drug Submission (ANDS)
- GABAPENTINSeptember 14, 2026 · NOC 38279 · Abbreviated New Drug Submission (ANDS)
- ROSUVASTATINSeptember 4, 2026 · NOC 38237 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ATORVASTATIN-10; ATORVASTATIN-20; ATORVASTATIN-40; ATORVASTATIN-80August 19, 2026 · NOC 38142 · Supplement to an Abbreviated New Drug Submission (SANDS)
- LEFLUNOMIDEAugust 13, 2026 · NOC 38101 · Supplement to an Abbreviated New Drug Submission (SANDS)
- APIXABANAugust 7, 2026 · NOC 38065 · Abbreviated New Drug Submission (ANDS)
- IMATINIBJuly 17, 2026 · NOC 37933 · Supplement to an Abbreviated New Drug Submission (SANDS)
- RIVAROXABANJuly 17, 2026 · NOC 37937 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ZOPICLONEJuly 13, 2026 · NOC 37894 · Supplement to a New Drug Submission (SNDS)
- CITALOPRAMJune 24, 2026 · NOC 37749 · Supplement to an Abbreviated New Drug Submission (SANDS)
- CELECOXIBJune 24, 2026 · NOC 37763 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MYCOPHENOLATE MOFETILJune 23, 2026 · NOC 37755 · Abbreviated New Drug Submission (ANDS)
- TOPIRAMATEJune 19, 2026 · NOC 37746 · Supplement to an Abbreviated New Drug Submission (SANDS)
- APIXABANJune 9, 2026 · NOC 37680 · Supplement to an Abbreviated New Drug Submission (SANDS)
- FINASTERIDEJune 5, 2026 · NOC 37669 · Supplement to an Abbreviated New Drug Submission (SANDS)
- CAPECITABINEMay 29, 2026 · NOC 37641 · Supplement to an Abbreviated New Drug Submission (SANDS)
- METFORMINMay 20, 2026 · NOC 37579 · Abbreviated New Drug Submission (ANDS)
- TERBINAFINEMay 12, 2026 · NOC 37526 · Abbreviated New Drug Submission (ANDS)
- CINACALCETApril 29, 2026 · NOC 37433 · Abbreviated New Drug Submission (ANDS)
- GABAPENTINApril 27, 2026 · NOC 37414 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DOMPERIDONE TABLETSMarch 31, 2026 · NOC 37235 · Abbreviated New Drug Submission (ANDS)
- IRBESARTANMarch 30, 2026 · NOC 37227 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DILTIAZEM CDMarch 12, 2026 · NOC 37088 · Supplement to a New Drug Submission (SNDS)
- IRBESARTAN HCTMarch 5, 2026 · NOC 37045 · Supplement to an Abbreviated New Drug Submission (SANDS)
- TENOFOVIRMarch 4, 2026 · NOC 37030 · Abbreviated New Drug Submission (ANDS)
- LAMOTRIGINEMarch 3, 2026 · NOC 37024 · Supplement to an Abbreviated New Drug Submission (SANDS)
- OLANZAPINEFebruary 17, 2026 · NOC 36920 · Supplement to an Abbreviated New Drug Submission (SANDS)
- LEFLUNOMIDEFebruary 13, 2026 · NOC 36898 · Supplement to an Abbreviated New Drug Submission (SANDS)
- CARVEDILOLJanuary 8, 2026 · NOC 36697 · Supplement to an Abbreviated New Drug Submission (SANDS)
- CETIRIZINEJanuary 2, 2026 · NOC 36667 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRAVASTATINDecember 11, 2025 · NOC 36523 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AMOXICILLINDecember 3, 2025 · NOC 36474 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ANASTROZOLENovember 28, 2025 · NOC 36443 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DULOXETINENovember 28, 2025 · NOC 36447 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PAROXETINENovember 14, 2025 · NOC 36381 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DUTASTERIDEOctober 23, 2025 · NOC 36258 · Abbreviated New Drug Submission (ANDS)
- GALANTAMINE EROctober 16, 2025 · NOC 36179 · Abbreviated New Drug Submission (ANDS)
- TAMSULOSIN CROctober 8, 2025 · NOC 36136 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AMIODARONESeptember 12, 2025 · NOC 35994 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ROSUVASTATINSeptember 11, 2025 · NOC 35982 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DONEPEZILAugust 25, 2025 · NOC 35895 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AMOXICILLINAugust 12, 2025 · NOC 35827 · Supplement to a New Drug Submission (SNDS)
- ZOPICLONEAugust 11, 2025 · NOC 35816 · Supplement to a New Drug Submission (SNDS)
- LAMOTRIGINEJuly 11, 2025 · NOC 35655 · Supplement to an Abbreviated New Drug Submission (SANDS)
- CLARITHROMYCINJuly 10, 2025 · NOC 35650 · Supplement to an Abbreviated New Drug Submission (SANDS)
- EZETIMIBEApril 17, 2025 · NOC 35209 · Supplement to an Abbreviated New Drug Submission (SANDS)
- CLARITHROMYCINApril 17, 2025 · NOC 35211 · Supplement to an Abbreviated New Drug Submission (SANDS)
- TELMISARTAN HCTZApril 14, 2025 · NOC 35189 · Supplement to an Abbreviated New Drug Submission (SANDS)
- TERBINAFINEMarch 31, 2025 · NOC 35091 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MONTELUKASTMarch 12, 2025 · NOC 35004 · Supplement to an Abbreviated New Drug Submission (SANDS)
- TELMISARTANMarch 7, 2025 · NOC 34976 · Abbreviated New Drug Submission (ANDS)
- FLUOXETINEFebruary 13, 2025 · NOC 34836 · Supplement to a New Drug Submission (SNDS)
- RABEPRAZOLEFebruary 12, 2025 · NOC 34825 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ZOLMITRIPTAN; ZOLMITRIPTAN ODTFebruary 7, 2025 · NOC 34807 · Supplement to an Abbreviated New Drug Submission (SANDS)
- TELMISARTAN HCTZFebruary 5, 2025 · NOC 34805 · Abbreviated New Drug Submission (ANDS)
- DESVENLAFAXINEJanuary 23, 2025 · NOC 34730 · Abbreviated New Drug Submission (ANDS)
- LISINOPRIL TABLETSJanuary 14, 2025 · NOC 34684 · Abbreviated New Drug Submission (ANDS)
- RIVAROXABANJanuary 14, 2025 · NOC 34688 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ALENDRONATEJanuary 8, 2025 · NOC 34650 · Supplement to an Abbreviated New Drug Submission (SANDS)
- BISOPROLOL TABLETSDecember 24, 2024 · NOC 34612 · New Drug Submission (NDS)
- TOPIRAMATEDecember 11, 2024 · NOC 34530 · Supplement to an Abbreviated New Drug Submission (SANDS)
- QUETIAPINE XRDecember 9, 2024 · NOC 34522 · Abbreviated New Drug Submission (ANDS)
- DONEPEZILDecember 5, 2024 · NOC 34506 · Abbreviated New Drug Submission (ANDS)
- ESCITALOPRAMDecember 4, 2024 · NOC 34487 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PREGABALINDecember 3, 2024 · NOC 34482 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SILDENAFILNovember 28, 2024 · NOC 34466 · Supplement to an Abbreviated New Drug Submission (SANDS)
- VALACYCLOVIRNovember 26, 2024 · NOC 34440 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PRAMIPEXOLENovember 15, 2024 · NOC 34388 · Supplement to an Abbreviated New Drug Submission (SANDS)
- LOSARTAN HCT; LOSARTAN HCT DSNovember 15, 2024 · NOC 34397 · Abbreviated New Drug Submission (ANDS)
- ATORVASTATIN-10; ATORVASTATIN-20; ATORVASTATIN-40; ATORVASTATIN-80October 30, 2024 · NOC 34304 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DUTASTERIDEOctober 29, 2024 · NOC 34299 · Supplement to an Abbreviated New Drug Submission (SANDS)
- TAMSULOSIN CROctober 23, 2024 · NOC 34266 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DOMPERIDONEOctober 22, 2024 · NOC 34264 · Supplement to a New Drug Submission (SNDS)
- ANASTROZOLEOctober 15, 2024 · NOC 34190 · Abbreviated New Drug Submission (ANDS)
- ROSUVASTATINOctober 4, 2024 · NOC 34143 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ROSUVASTATINOctober 1, 2024 · NOC 34110 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MOMETASONESeptember 20, 2024 · NOC 34051 · Abbreviated New Drug Submission (ANDS)
- VALSARTAN HCTSeptember 18, 2024 · NOC 34044 · Abbreviated New Drug Submission (ANDS)
- FINASTERIDESeptember 6, 2024 · NOC 33965 · Supplement to an Abbreviated New Drug Submission (SANDS)
- LISINOPRILSeptember 4, 2024 · NOC 33929 · Supplement to a New Drug Submission (SNDS)
- SIMVASTATINAugust 30, 2024 · NOC 33906 · Supplement to an Abbreviated New Drug Submission (SANDS)
- OLANZAPINEAugust 22, 2024 · NOC 33857 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ATOMOXETINEAugust 14, 2024 · NOC 33819 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AMOXICILLINJuly 24, 2024 · NOC 33710 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ARIPIPRAZOLEJuly 22, 2024 · NOC 33691 · Supplement to an Abbreviated New Drug Submission (SANDS)
- OMEPRAZOLE-20July 19, 2024 · NOC 33682 · Supplement to an Abbreviated New Drug Submission (SANDS)
- VENLAFAXINE XRJune 27, 2024 · NOC 33537 · Supplement to an Abbreviated New Drug Submission (SANDS)
- FAMOTIDINEJune 26, 2024 · NOC 33526 · New Drug Submission (NDS)
- ROSUVASTATINJune 21, 2024 · NOC 33498 · Supplement to an Abbreviated New Drug Submission (SANDS)
- LEVETIRACETAMJune 20, 2024 · NOC 33475 · Supplement to an Abbreviated New Drug Submission (SANDS)
- GABAPENTINJune 20, 2024 · NOC 33476 · Supplement to an Abbreviated New Drug Submission (SANDS)
- LANSOPRAZOLEJune 7, 2024 · NOC 33414 · Abbreviated New Drug Submission (ANDS)
- AZITHROMYCINMay 28, 2024 · NOC 33323 · Supplement to an Abbreviated New Drug Submission (SANDS)
- GABAPENTINMay 3, 2024 · NOC 33173 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AMIODARONEMay 2, 2024 · NOC 33161 · Supplement to an Abbreviated New Drug Submission (SANDS)
- CITALOPRAMApril 26, 2024 · NOC 33128 · Supplement to an Abbreviated New Drug Submission (SANDS)
- LOSARTANApril 25, 2024 · NOC 33118 · Abbreviated New Drug Submission (ANDS)
- PREGABALINApril 23, 2024 · NOC 33097 · Supplement to an Abbreviated New Drug Submission (SANDS)
The latest 100 of 446.